The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1180
ISSUE1180
April 12, 2004
Pemetrexed (Alimta) for Mesothelioma
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Pemetrexed (Alimta) for Mesothelioma
April 12, 2004 (Issue: 1180)
The combination of pemetrexed (Alimta - Lilly) and cisplatin is the first chemotherapy regimen approved by the FDA for treatment of malignant pleural mesothelioma. This uncommon malignancy, which has been linked to asbestos exposure, was previously...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.